[1] 骆抗先.乙型肝炎基础和临床[M].第2版,北京:人民卫生出版社,2001.390. [2] 中华传染病与寄生虫病学会,中华肝病学会.病毒性肝炎防治方案[J].中华传染病杂志(Chin J Infect Dis),2001,19(1):56-62. [3] 林小田,骆抗先,冯筱榕,等慢性乙型肝炎临床与病理分级、分期的对比分析[J].中华内科杂志,1998,37(7):437-9.Lin XT,Luo KX,Feng XR,et al.The comparison of clinical manifestation and pathological grading and staging of chronic hepatitis B[J].Chin J Intem Med,1998,37(7):437-9. [4] 黄莉萍,陈水鹏,丁红兵,等.肿纤维化血清指标与慢性肿炎肿组织炎症及纤维化相关性分析[J].第一军医大学学报,2001,21(2):116-7.Huang LP,Chen YP,Ding HB,et al.Correlation between serum markers for liver fibrosis and the degree of liver inflammation and fibrosis in patients with chronic hepatitis [J].J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2001,21(2):116-7. [5] Guéchot J,Loria A,Serfaty L,et al.Serum hyaluronate as a marker of liver fibrosis in chronic viral hepatitis C:effect of alpha interferon therapy[J].J Hepatol,1995,22(1):22-6. [6] 陈永鹏,戴琳,冯筱榕,等.超声波检查对肝脏纤维化分期的诊断价值分析[J].中华肝脏病杂志(Chin J Hepatic),2002,10(2):132-4 [7] 杨永平,张世兰,李亚洁,等.慢性病毒性肝炎门脉血流速度、血流量与血清纤维化指标及肝组织病理改变的关系[J].第一军医大学学报,2002,22(4):341-3.Yang YP,Zhan SL,Li YJ,et al.Changes in the hemodynamic parameters of the portal vein and serum fibrosis markers in patients with chronic viral hepatitis B [J].J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2002,22(4):341-3. [8] Chen YP,Feng XR,Dai L,et al.Non-invasive diagnostic screening of hepatic fibrosis in patients with chronic hepatitis B [J].Chin Med J,2004,117(7):1109-12. [9] 黄唯,龚飞跃.血清生化指标对乙型肝炎肝硬化的诊断价值[J].第一军医大学学报,2002,22(11):1034-6.Huang W,Gong FY.Diagnostic value of serum biochemical markers for liver fibrosis in patients with hepatitis B virus [J].J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2002,22(11):1034-6. |